-
ArticlePublication 2008Potential Cost-Effectiveness of Vaccination against Herpes Zoster and Post-Herpetic Neuralgia
This 2008 Canadian study assessed the cost effectiveness of the Zoster Vaccine Live (ZVL) vaccine …
This 2008 Canadian study assessed the cost effectiveness of the Zoster Vaccine Live (ZVL) vaccine against herpes zoster (HZ) and post-herpetic neuralgia (PHN). The authors used a cohort model to estimate the burden of HZ and the cost-effectiveness of HZ vaccination from a ministry of health perspective using Canadian population-based data. They examined different ages at vaccination and conducted probabilistic sensitivity analysis.There are about 130,000 new cases of HZ, 17,000 cases of PHN and 20 deaths…
Cost-Effectiveness Analysis | North America | Preferences/Values | Dynamic Transmission | Infectious Diseases | Health/Medicine -
ArticlePublication 2015Cost-Effectiveness of Herpes Zoster Vaccine for Persons Aged 50 Years
This article reports on a cost-effectiveness analysis of the original herpes zoster (HZ) vaccine (ZVL) …
This article reports on a cost-effectiveness analysis of the original herpes zoster (HZ) vaccine (ZVL) that at the time of this study was approved for persons age 50+. The authors used a Markov model to simulate adults aged 50 years over a lifetime from a societal perspective; outcomes included the number of HZ and postherpetic neuralgia (PHN) cases prevented and the incremental cost per quality-adjusted life-year (QALY) saved. Their focus was on the cost effectiveness…
Cost-Effectiveness Analysis | North America | State-Transition | Infectious Diseases | Health Systems | Health/Medicine
2 Shown
Teaching Resources
Collections
Format
Learner Level
Teaching Topic